PBYI vs. VOO
Compare and contrast key facts about Puma Biotechnology, Inc. (PBYI) and Vanguard S&P 500 ETF (VOO).
VOO is a passively managed fund by Vanguard that tracks the performance of the S&P 500 Index. It was launched on Sep 7, 2010.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PBYI or VOO.
Correlation
The correlation between PBYI and VOO is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PBYI vs. VOO - Performance Comparison
Key characteristics
PBYI:
-0.79
VOO:
1.89
PBYI:
-1.11
VOO:
2.54
PBYI:
0.86
VOO:
1.35
PBYI:
-0.59
VOO:
2.83
PBYI:
-1.20
VOO:
11.83
PBYI:
49.29%
VOO:
2.02%
PBYI:
75.04%
VOO:
12.66%
PBYI:
-99.40%
VOO:
-33.99%
PBYI:
-98.94%
VOO:
-0.42%
Returns By Period
In the year-to-date period, PBYI achieves a -4.26% return, which is significantly lower than VOO's 4.17% return. Over the past 10 years, PBYI has underperformed VOO with an annualized return of -34.84%, while VOO has yielded a comparatively higher 13.26% annualized return.
PBYI
-4.26%
-2.01%
19.67%
-55.15%
-26.56%
-34.84%
VOO
4.17%
1.23%
10.51%
24.45%
14.68%
13.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PBYI vs. VOO — Risk-Adjusted Performance Rank
PBYI
VOO
PBYI vs. VOO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Puma Biotechnology, Inc. (PBYI) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PBYI vs. VOO - Dividend Comparison
PBYI has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.19%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBYI Puma Biotechnology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VOO Vanguard S&P 500 ETF | 1.19% | 1.24% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% | 1.85% |
Drawdowns
PBYI vs. VOO - Drawdown Comparison
The maximum PBYI drawdown since its inception was -99.40%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for PBYI and VOO. For additional features, visit the drawdowns tool.
Volatility
PBYI vs. VOO - Volatility Comparison
Puma Biotechnology, Inc. (PBYI) has a higher volatility of 10.82% compared to Vanguard S&P 500 ETF (VOO) at 2.94%. This indicates that PBYI's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.